BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 8688083)

  • 1. Protection against atherogenesis in mice mediated by human apolipoprotein A-IV.
    Duverger N; Tremp G; Caillaud JM; Emmanuel F; Castro G; Fruchart JC; Steinmetz A; Denèfle P
    Science; 1996 Aug; 273(5277):966-8. PubMed ID: 8688083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of human apolipoprotein A-I/C-III/A-IV gene cluster in mice induces hyperlipidemia but reduces atherogenesis.
    Vergnes L; Baroukh N; Ostos MA; Castro G; Duverger N; Nanjee MN; Najib J; Fruchart JC; Miller NE; Zakin MM; Ochoa A
    Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2267-74. PubMed ID: 11031214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased susceptibility to diet-induced atherosclerosis in human apolipoprotein A-II transgenic mice.
    Tailleux A; Bouly M; Luc G; Castro G; Caillaud JM; Hennuyer N; Poulain P; Fruchart JC; Duverger N; Fiévet C
    Arterioscler Thromb Vasc Biol; 2000 Nov; 20(11):2453-8. PubMed ID: 11073852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antioxidative and antiatherosclerotic effects of human apolipoprotein A-IV in apolipoprotein E-deficient mice.
    Ostos MA; Conconi M; Vergnes L; Baroukh N; Ribalta J; Girona J; Caillaud JM; Ochoa A; Zakin MM
    Arterioscler Thromb Vasc Biol; 2001 Jun; 21(6):1023-8. PubMed ID: 11397714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of macrophage-derived apolipoprotein E on plasma lipoprotein distribution of apolipoprotein A-I in apolipoprotein E-deficient mice.
    Spangenberg J; Curtiss LK
    Biochim Biophys Acta; 1997 Nov; 1349(2):109-21. PubMed ID: 9421184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human apolipoprotein A-I prevents atherosclerosis associated with apolipoprotein[a] in transgenic mice.
    Liu AC; Lawn RM; Verstuyft JG; Rubin EM
    J Lipid Res; 1994 Dec; 35(12):2263-7. PubMed ID: 7897323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice.
    Joyce CW; Amar MJ; Lambert G; Vaisman BL; Paigen B; Najib-Fruchart J; Hoyt RF; Neufeld ED; Remaley AT; Fredrickson DS; Brewer HB; Santamarina-Fojo S
    Proc Natl Acad Sci U S A; 2002 Jan; 99(1):407-12. PubMed ID: 11752403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of apoA-I is not associated with increased susceptibility to atherosclerosis in mice.
    Li H; Reddick RL; Maeda N
    Arterioscler Thromb; 1993 Dec; 13(12):1814-21. PubMed ID: 8241102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of human apolipoprotein A-I/C-III/A-IV gene cluster in mice reduces atherogenesis in response to a high fat-high cholesterol diet.
    Baroukh N; Ostos MA; Vergnes L; Recalde D; Staels B; Fruchart J; Ochoa A; Castro G; Zakin MM
    FEBS Lett; 2001 Jul; 502(1-2):16-20. PubMed ID: 11478940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human apolipoprotein A-IV reduces secretion of proinflammatory cytokines and atherosclerotic effects of a chronic infection mimicked by lipopolysaccharide.
    Recalde D; Ostos MA; Badell E; Garcia-Otin AL; Pidoux J; Castro G; Zakin MM; Scott-Algara D
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):756-61. PubMed ID: 14751811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenoviral vector-mediated overexpression of serum amyloid A in apoA-I-deficient mice.
    Webb NR; de Beer MC; van der Westhuyzen DR; Kindy MS; Banka CL; Tsukamoto K; Rader DL; de Beer FC
    J Lipid Res; 1997 Aug; 38(8):1583-90. PubMed ID: 9300780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysfunctional HDL containing L159R ApoA-I leads to exacerbation of atherosclerosis in hyperlipidemic mice.
    Sorci-Thomas MG; Zabalawi M; Bharadwaj MS; Wilhelm AJ; Owen JS; Asztalos BF; Bhat S; Thomas MJ
    Biochim Biophys Acta; 2012 Mar; 1821(3):502-12. PubMed ID: 21944998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein A-I protection against atherosclerosis is dependent on genetic background.
    Sontag TJ; Krishack PA; Lukens JR; Bhanvadia CV; Getz GS; Reardon CA
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):262-9. PubMed ID: 24334873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined effects of cholesterol reduction and apolipoprotein A-I expression on atherosclerosis in LDL receptor deficient mice.
    Kawashiri MA; Zhang Y; Puré E; Rader DJ
    Atherosclerosis; 2002 Nov; 165(1):15-22. PubMed ID: 12208466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex as a profound modifier of atherosclerotic lesion development in apolipoprotein E-deficient mice with different genetic backgrounds.
    Surra JC; Guillén N; Arbonés-Mainar JM; Barranquero C; Navarro MA; Arnal C; Orman I; Segovia JC; Osada J
    J Atheroscler Thromb; 2010 Jul; 17(7):712-21. PubMed ID: 20460831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term feeding of atherogenic diet to mice results in reduction of HDL and paraoxonase that may be mediated by an immune mechanism.
    Hedrick CC; Hassan K; Hough GP; Yoo JH; Simzar S; Quinto CR; Kim SM; Dooley A; Langi S; Hama SY; Navab M; Witztum JL; Fogelman AM
    Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):1946-52. PubMed ID: 10938016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E gene expression is reduced in apolipoprotein A-I transgenic mice.
    Srivastava RA
    Mol Cell Biochem; 2000 Jun; 209(1-2):125-9. PubMed ID: 10942210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI.
    Rubin EM; Krauss RM; Spangler EA; Verstuyft JG; Clift SM
    Nature; 1991 Sep; 353(6341):265-7. PubMed ID: 1910153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpressed lipoprotein lipase protects against atherosclerosis in apolipoprotein E knockout mice.
    Yagyu H; Ishibashi S; Chen Z; Osuga J; Okazaki M; Perrey S; Kitamine T; Shimada M; Ohashi K; Harada K; Shionoiri F; Yahagi N; Gotoda T; Yazaki Y; Yamada N
    J Lipid Res; 1999 Sep; 40(9):1677-85. PubMed ID: 10484615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transgenic mice expressing high levels of human apolipoprotein B develop severe atherosclerotic lesions in response to a high-fat diet.
    Purcell-Huynh DA; Farese RV; Johnson DF; Flynn LM; Pierotti V; Newland DL; Linton MF; Sanan DA; Young SG
    J Clin Invest; 1995 May; 95(5):2246-57. PubMed ID: 7738190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.